NovantaNOVT
Market Cap: $6.05B
About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Employees: 2,900
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
25% more call options, than puts
Call options by funds: $2.35M | Put options by funds: $1.88M
18% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 92
0.18% more ownership
Funds ownership: 96.82% [Q1] → 97.0% (+0.18%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
4% less funds holding
Funds holding: 280 [Q1] → 268 (-12) [Q2]
6% less capital invested
Capital invested by funds: $6.06B [Q1] → $5.68B (-$386M) [Q2]
36% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 33
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Baird Robert Mason 57% 1-year accuracy 4 / 7 met price target | 4%upside $175 | Neutral Maintained | 7 Aug 2024 |